Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

CEP135 may predict cancer outcomes, and targeting PLK1 could help treat certain sarcomas.

CENPV, a new partner of CYLD, helps regulate ciliary acetylated tubulin and is overexpressed in certain skin tumors.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

Hair follicle samples effectively show how well the drug MK-0752 targets and engages with the Notch pathway.

Deleting the MAD2L1 gene in mice led to rapid tumor growth despite chromosomal instability.

Targeted therapy with Ustekinumab significantly improved a skin condition called ILVEN, which is caused by mutations in the CARD14 gene.

LGR5 helps maintain corneal cell characteristics and prevents unwanted changes by controlling specific cell signaling pathways.

Brg1 is crucial for keeping hair follicle stem cells and repairing skin, working with the Sonic Hedgehog pathway to promote hair growth.

Vitamin D receptor helps control skin cell growth and hair development.

AgK114 protein helps in hamster skin injury recovery.

Colorectal cancer uses wound-healing processes to spread, suggesting new treatment targets.

CaM7 and CNGC14 interaction controls root hair growth in Arabidopsis.

RANK-RANKL signaling is essential for hair growth and skin health.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

The study concluded that a protein important for hair strength is regulated by certain molecular processes and is affected by growth phases.

Mutations in the AP1B1 gene cause a new syndrome with skin, hearing, and developmental issues.

A bull with a gene mutation was asymptomatic, synthetic retinoids cause hair loss, and new therapeutic targets were identified for skin diseases.

Mouse keratin 6 genes evolved independently from human ones and are regulated differently.

KIF18B is important for correctly positioning cell division machinery in skin cells, affecting hair follicle development.

A specific molecular switch, driven by MAPK/ERK signaling, helps spiny mice heal wounds by regenerating skin instead of forming scars.

CK15 is not a reliable marker for stem cells in damaged hair follicles from patients with CCCA.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

The balance between cell renewal and differentiation controls the growth of cancerous cells in mouse skin.

A new mutation in the TRPS1 gene was found in a Ukrainian girl with Trichorhinophalangeal syndrome type I.

The newborn's skin blistering is due to a genetic condition called epidermolytic hyperkeratosis.

The mutated hairless gene causes hair loss by acting as a new type of corepressor affecting thyroid hormone receptors.

Dermal EZH2 controls skin cell development and hair growth in mice.

RIPK1 inhibitors may help prevent alopecia areata by reducing immune cell activity.